Lebanon has a primary registry, Lebanon Clinical Trials Registry. It is a World Health Organization (WHO) recognized primary registry. It has a provision to register the protocol and post the summary results. The registration of interventional, Phase 2-4 clinical trials conducted in Lebanon is mandatory, while it is voluntary for observational studies. LBCTR is managed by the Lebanese Ministry of Public Health (MOPH).
| Registries at a Glance | |||||
| Registry | PHUSE Categorization | Information to be Entered By | Route of Data in Registry | Study Type | Language |
| LBCTR | Mandatory National Database (includes Ethics Requirement) | Sponsor | Through a dedicated registration platform (process independent from clinical trial application) |
Interventional (Phase 2-4) |
English 
Arabic |
| Registration and Results Requirements | |||
| Registry | Activity | Legal Requirement | Timing |
| LBCTR | Registration |
Yes |
Prior to enrollment |
| Results |
Yes |
Within 1 year of study completion date | |
Registry Updates
- Lebanese CTR: New Primary Registry in ICTRP - On 25 July 2019, the Lebanese Clinical Trials Registry (LBCTR) became a member of the Primary Registry Network of ICTRP. LBCTR is also becoming a data provider and trials registered with LBCTR will be added to the ICTRP database. LBCTR was established by the Lebanese Ministry of Public Health with the support of the WHO … Continue reading "Lebanese CTR: New Primary Registry in ICTRP"
References
- International Clinical Trials Registry Platform (ICTRP) Registry Profile. https://www.who.int/docs/default-source/clinical-trials/lbctr-registry-profile.pdf?sfvrsn=3ab3ba4e_2. Accessed January 06, 2022.